Nicolas G Bazan Selected Research

platelet activating factor receptor

8/2022	Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window.
10/2020	Blocking pro-inflammatory platelet-activating factor receptors and activating cell survival pathways: A novel therapeutic strategy in experimental ischemic stroke.
2/2009	LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat.
4/2004	Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist.
4/2004	Platelet-activating factor receptor-deficient mice are protected from experimental sleep apnea-induced learning deficits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas G Bazan Research Topics

Disease

21	Brain Ischemia (Cerebral Ischemia) 01/2017 - 11/2002
20	Stroke (Strokes) 05/2022 - 06/2002
19	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 06/2002
14	Inflammation (Inflammations) 04/2022 - 08/2002
13	Ischemic Stroke 05/2022 - 10/2002
11	Ischemia 01/2017 - 10/2002
9	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2022 - 11/2002
9	Infarction (Infarctions) 11/2020 - 07/2002
9	Retinal Degeneration 01/2018 - 11/2002
8	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 08/2005
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 08/2005
6	Cognitive Dysfunction 04/2022 - 10/2005
6	Seizures (Absence Seizure) 05/2020 - 01/2002
6	Wounds and Injuries (Trauma) 12/2014 - 04/2004
5	COVID-19 01/2022 - 08/2020
5	Neuroinflammatory Diseases 12/2021 - 05/2005
4	Neoplasms (Cancer) 01/2021 - 03/2004
4	Epilepsy (Aura) 01/2016 - 06/2002
4	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2013 - 05/2006
4	Choroidal Neovascularization 01/2013 - 03/2010
4	Nervous System Diseases (Neurological Disorders) 09/2005 - 06/2002
4	Hypoxia (Hypoxemia) 05/2004 - 08/2002
3	Neuralgia (Stump Neuralgia) 01/2021 - 11/2010
3	Brain Edema (Cerebral Edema) 07/2015 - 01/2005
3	Brain Injuries (Brain Injury) 01/2013 - 02/2003
3	Dry Eye Syndromes (Dry Eye Syndrome) 02/2010 - 09/2005
3	Sleep Deprivation 05/2006 - 02/2006
3	Pathologic Processes 04/2006 - 08/2004
2	Cerebral Hemorrhage 04/2022 - 05/2020
2	Thrombocytopenia (Thrombopenia) 11/2021 - 01/2021
2	Virus Diseases (Viral Diseases) 10/2021 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2021
2	Temporal Lobe Epilepsy 01/2016 - 09/2011
2	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2015 - 10/2013
2	Blindness (Hysterical Blindness) 03/2015 - 03/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2015 - 07/2002
2	Necrosis 10/2013 - 04/2004
2	Deafness (Deaf Mutism) 03/2013 - 03/2010
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2012 - 10/2003
2	Eye Diseases (Eye Disease) 11/2011 - 05/2007
2	Reperfusion Injury 04/2010 - 09/2005
2	Keratitis 02/2010 - 04/2004

Drug/Important Bio-Agent (IBA)

30	Docosahexaenoic AcidsIBA 11/2020 - 10/2002
26	LipidsIBA 04/2022 - 08/2002
24	protectin D1IBA 08/2022 - 04/2005
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2003
12	Platelet Activating FactorIBA 10/2020 - 07/2002
12	Retinaldehyde (Retinal)IBA 01/2018 - 10/2003
10	Retinal Pigments (Pigments, Visual)IBA 05/2022 - 08/2005
8	EnzymesIBA 01/2021 - 06/2002
8	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 07/2002
7	CytokinesIBA 05/2022 - 10/2003
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 11/2002
7	ProstaglandinsIBA 01/2018 - 06/2002
6	Arachidonic Acid (Vitamin F)IBA 01/2018 - 06/2002
5	platelet activating factor receptorIBA 08/2022 - 04/2004
5	AlbuminsIBA 02/2014 - 11/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 10/2003
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 01/2005
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 02/2006
4	Glutamic Acid (Glutamate)FDA Link 01/2017 - 01/2002
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2011 - 08/2002
4	Secretory Phospholipases A2IBA 05/2007 - 07/2002
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2005 - 06/2002
4	Phospholipases A2 (Phospholipase A2)IBA 04/2005 - 08/2002
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2022 - 10/2003
3	Peptides (Polypeptides)IBA 12/2021 - 08/2002
3	Oxygen (Dioxygen)IBA 01/2021 - 10/2002
3	LAU 0901IBA 01/2021 - 04/2004
3	Neuroprotective AgentsIBA 01/2013 - 11/2002
3	Human Serum Albumin FDA LinkGeneric 09/2012 - 11/2002
3	Phospholipases (Phospholipase)IBA 05/2007 - 02/2003
2	Amyloid (Amyloid Fibrils)IBA 04/2022 - 12/2021
2	InterferonsIBA 01/2022 - 07/2015
2	VaccinesIBA 11/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 11/2021 - 05/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2003
2	ChemokinesIBA 01/2021 - 11/2011
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021 - 12/2014
2	Cell Surface ReceptorsIBA 11/2020 - 04/2004
2	Acetaminophen (Paracetamol)FDA LinkGeneric 09/2020 - 11/2010
2	AntioxidantsIBA 09/2020 - 08/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 12/2004
2	SaltsIBA 01/2017 - 07/2012
2	EstersIBA 01/2017 - 07/2012
2	SodiumIBA 01/2017 - 07/2012
2	Myosin-Light-Chain KinaseIBA 07/2015 - 10/2013
2	Isoflurane FDA LinkGeneric 02/2014 - 02/2009
2	interstitial retinol-binding proteinIBA 10/2013 - 04/2013
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2013 - 10/2005
2	N-Methylaspartate (NMDA)IBA 02/2006 - 01/2002
2	DiglyceridesIBA 06/2005 - 12/2004
2	Nonesterified Fatty Acids (NEFA)IBA 12/2004 - 11/2002
2	NF-kappa B (NF-kB)IBA 10/2003 - 10/2002
2	EicosanoidsIBA 02/2003 - 10/2002

Therapy/Procedure

16	Therapeutics 01/2021 - 11/2002
4	Sutures (Suture) 02/2014 - 01/2005
3	Lasers (Laser) 01/2013 - 03/2010
2	Refractive Surgical Procedures 11/2017 - 02/2010
1	Intranasal Administration 01/2022